In stockResearch use only24h dispatchLot-tracked COA
VaultLabs UAE
SS-31 for UAE laboratories
SS-31 10mg is a sealed 10 mg vial of the mitochondria-targeting tetrapeptide D-Arg-Dmt-Lys-Phe-NH2. Procurement messages call it elamipretide, Bendavia or MTP-131 — those are development names for the same sequence, not extra SKUs. This page covers naming, why a standard tyrosine method does not transfer, and how to retrieve the lot record. Identity data sits on the SS-31 monograph. Supplied for in vitro laboratory research only.
Third-party testedVaultLabs tested · 99.91%
Tested before release
Each catalogue batch is tested by an independent laboratory before release, then checked again on the VaultLabs certificate. The laboratory report for this lot is available on request, and the laboratory is named on that report.
Lot VL-SS31-20260917 · 99.91%
One sequence, four names on the purchase order
SS-31, elamipretide, Bendavia and MTP-131 all refer to this tetrapeptide when the masses match. VaultLabs releases one fill: 10 mg lyophilised powder, CAS 736992-21-5, molecular weight 639.79 g/mol. Write the CAS number on the inventory row so a method that uses any of those names still maps to the lot you hold.
The unit is a single-sequence vial, not a kit and not a dual-strength pack. Diluent is a separate catalogue line. MOT-C 10mg is a different mitochondrial-associated sequence with its own lots — adjacency on a metabolic shelf is not interchangeability.
Why the residue list matters at goods-in
The sequence includes D-arginine and 2,6-dimethyltyrosine (Dmt). Incoming methods written for all-L tyrosine peptides do not automatically apply. The published record should state how identity was confirmed for this non-canonical tetrapeptide, not only a headline purity percentage.
Protect solutions from unnecessary light once the vial is opened. That handling note is specific to this line and belongs in the notebook entry next to the lot, not only in a general peptide SOP.
Certificates, dispatch and neighbouring lines
Verify the printed lot in batch verification or from the SS-31 COA index. A MOT-C or NAD+ certificate cannot release this vial. If the lot is unpublished, raise a documentation request and hold the unit. The COA interpretation guide explains how to read method and document type.
Dispatch covers the seven emirates with AED checkout. Store sealed vials at 2–8 °C, protected from light and moisture, and transfer them into laboratory storage on the day they arrive. Category context sits on the research peptides UAE hub.
Research-use-only positioning
A pharmaceutical development programme exists for elamipretide under other controls. VaultLabs supplies research-grade lyophilised powder for in vitro laboratory work only. That is a different product category with different obligations.
SS-31 is not supplied for human or animal use, personal use or medical application. VaultLabs makes no statements about mitochondrial, cardiac or physiological effects and provides no administration or preparation guidance for living systems.
Frequently asked questions
Those names usually refer to the same D-Arg-Dmt-Lys-Phe-NH2 sequence. Confirm CAS 736992-21-5 and the 10 mg fill. A different mass is a different material.
No. MOT-C is a separate mitochondrial open-reading-frame peptide with its own lots and certificates. Do not share records.
Identity confirmation appropriate to a Dmt-containing sequence, plus lot, strength and document type. A generic tyrosine-peptide method note is not enough on its own.
No. VaultLabs supplies research-grade powder for in vitro laboratory use only, not a pharmaceutical product and not for human use.
All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.